INDRAPRASTHS MEDIC chart

Last update: 2022-06-03
Key statistics and financials
Revenue per share 96.82
Dividend & YieldN/A₹ (N/A)
Beta 0.67
Market capitalization 5.5B
Operating cash flow 712.9M
ESG Scores unknown

Company description

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow transplant, cancer, cardiac and cardiology, dermatology, dietetics and clinical nutrition, emergency care, endovascular surgery, endocrinology/diabetes care, ENT, fetal medicine, gastroenterology and hepatology, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedic, pediatric urology and pediatric surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, robotic surgery, spine surgery, transfusion medicine, transplant, and urology and andrology. The company operates cosmetic and dental clinics. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India.

Sector: Healthcare - Industry: Medical Care Facilities

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities 41.38M 164.97M -141.23M -281.5M
Total Cashflows From Investing Activities -166.99M -401.93M -201.62M -511M
Net Borrowings -260M -228.49M -20.93M -25.1M
Total Cash From Financing Activities -441.84M -427.44M -31.47M -33.7M
Change To Operating Activities
Issuance Of Stock
Net Income 284.13M 436.24M 23.29M 586.2M
Change In Cash 143.02M 35.14M 45.89M 168.2M
Effect Of Exchange Rate
Total Cash From Operating Activities 751.85M 864.51M 278.98M 712.9M
Depreciation 288.52M 323.55M 318.8M 349.4M
Change To Account Receivables 83.47M 27.57M 96.07M 29.4M
Other Cashflows From Financing Activities -20.7M -20.32M -8.09M -6M
Change To Netincome 37.25M -56.43M -65.65M 41.9M
Capital Expenditures -170.94M -409.18M -209.63M -294.8M

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development
Income Before Tax 446.21M 481.92M 42.89M 790.7M
Net Income 284.13M 436.24M 23.29M 586.2M
Selling General Administrative 482.97M 509.79M 284.45M
Gross Profit 4.25B 4.46B 2.88B 2.9B
Ebit 524.49M 544.36M 76.59M 793.6M
Operating Income 524.49M 544.36M 76.59M 793.6M
Interest Expense -30.01M -11.31M -40k -34.1M
Income Tax Expense 162.08M 45.68M 19.6M 204.5M
Total Revenue 7.88B 8.31B 6.13B 8.88B
Cost Of Revenue 3.63B 3.85B 3.26B 5.98B
Total Other Income ExpenseNet -78.28M -62.44M -33.7M -2.9M
Net Income From Continuing Ops 284.13M 436.24M 23.29M 586.2M
Net Income Applicable To Common Shares 284.13M 436.24M 23.29M 586.2M

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 1.78B 1.81B 1.59B 1.36B
Total Stockholder Equity 2.44B 2.68B 2.73B 3.25B
Other Current Liabilities 163.27M 143.47M 88.85M 130.5M
Total Assets 4.22B 4.49B 4.32B 4.62B
Common Stock 916.73M 916.73M 916.73M 916.7M
Other Current Assets 60.38M 46.5M 29.08M 187.7M
Retained Earnings 1.52B 1.78B 1.8B
Treasury Stock 5.38M -15.1M 11.17M 2.34B
Cash 168.18M 203.32M 249.21M 684.5M
Total Current Liabilities 1.24B 1.4B 1.16B 935M
Other Stockholder Equity 5.38M -15.1M 11.17M 2.34B
Property, Plant, and Equipment 2.81B 3.01B 2.83B 2.75B
Total Current Assets 1.36B 1.41B 1.41B 1.57B
Net Tangible Assets 2.44B 2.66B 2.69B 3.24B
Net Receivables 940.51M 982.92M 944.27M 602.2M
Accounts Payable 375.69M 433.09M 397.95M 767.5M


Insider Transactions

Here are the insider transactions of stock shares related to INDRAPRASTHS MEDIC:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Apollo Hospitals Enterprise LtdD2011-12-30Promoter1.17M
Apollo Hospitals Enterprise LtdD2010-03-18Promoter1.97M

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to INDRAPRASTHS MEDIC. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on INDRAPRASTHS MEDIC

Here is the result of two systematic investment strategies applied to INDRAPRASTHS MEDIC. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on INDRAPRASTHS MEDIC

The following chart shows the equity curve of the two systematic investment strategies applied to INDRAPRASTHS MEDIC:

INDRAPRASTHS MEDIC automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 19.11% on the backtest period.

Performance at glance

Performance

19.11 %

Latent gain

477.75 ₹

Invested capital

2500.65 ₹

Annualized return

4.53 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on INDRAPRASTHS MEDIC

This is the result of two momentum investment strategies applied to INDRAPRASTHS MEDIC. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on INDRAPRASTHS MEDIC

The following chart shows all the entries opened by the momentum investment system on INDRAPRASTHS MEDIC:

INDRAPRASTHS MEDIC momentum entries
  • The first momentum investment strategy would give 25.69% of return on INDRAPRASTHS MEDIC. That represents 1265.2₹ of latent gain with 4925.2₹ of employed capital.
  • The second momentum investment strategy would give 33.28% of return on INDRAPRASTHS MEDIC. That represents 1516.6₹ of latent gain with 4557.0₹ of employed capital.
Performance at glance (1Q Momentum)

Performance

25.69 %

Latent gain

1265.2 ₹

Invested capital

4925.2 ₹

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

33.28 %

Latent gain

1516.6 ₹

Invested capital

4557.0 ₹

Annualized return

8.9 %

Momentum equity curve on INDRAPRASTHS MEDIC

The following chart shows the equity curve of the two momentum strategies applied to INDRAPRASTHS MEDIC:

INDRAPRASTHS MEDIC momentum equity

Note: the dividends potentially given by INDRAPRASTHS MEDIC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on INDRAPRASTHS MEDIC

The following chart shows the employed capital evolution of the two momentum strategies on INDRAPRASTHS MEDIC since the beginning:

INDRAPRASTHS MEDIC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250₹, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000₹.


Buy the dip strategy result on INDRAPRASTHS MEDIC

Buy the dip entry openings on INDRAPRASTHS MEDIC

INDRAPRASTHS MEDIC

The performance achieved by the robo-advisor on INDRAPRASTHS MEDIC is 0%. That represents 0.0$ of latent gain with 0.0₹ of employed capital. The following chart shows INDRAPRASTHS MEDIC stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of INDRAPRASTHS MEDIC, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 ₹

Invested capital

0.0 ₹

Annualized return

0.0 %

Equity curve of the strategy applied to INDRAPRASTHS MEDIC

The following chart shows the result of the investment strategy applied to INDRAPRASTHS MEDIC:

INDRAPRASTHS MEDIC

Note: the dividends potentially given by INDRAPRASTHS MEDIC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on INDRAPRASTHS MEDIC

The following chart shows the employed capital evolution since the beginning of the investment strategy on INDRAPRASTHS MEDIC:

INDRAPRASTHS MEDIC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on INDRAPRASTHS MEDIC

In this section, I will compare the three previous investment strategies applied to INDRAPRASTHS MEDIC.

Equity curve comparison on INDRAPRASTHS MEDIC

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

INDRAPRASTHS MEDIC investment strategy comparison

Employed capital comparison on INDRAPRASTHS MEDIC

INDRAPRASTHS MEDIC investment comparison

Performance comparison on INDRAPRASTHS MEDIC

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 19.11% 477.75₹ 2500.65₹ 4.53%
Momentum 1 quarter 25.69% 1265.2₹ 4925.2₹ 6.45%
Momentum 2 quarters 33.28% 1516.6₹ 4557.0₹ 8.9%
Non-directional 0% 0.0₹ 0.0₹ 0.0%
Annualized return comparison

Automatic investment

4.53 %

Momentum 1Q

8.9 %

Momentum 2Q

8.9 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with INDRAPRASTHS MEDIC:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between INDRAPRASTHS MEDIC and the other stocks. There may be false positives or some missing correlated stocks. If the price of INDRAPRASTHS MEDIC does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name INDRAPRASTHS MEDIC
Country India
City New Delhi
Address Sarita Vihar
Phone 91 11 2692 5858
Website www.delhi.apollohospitals.com
FullTime employees
Industry Medical Care Facilities
Sector Healthcare
Exchange XNSE
Ticker INDRAMEDCO.XNSE
Market

INDRAPRASTHS MEDIC ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown